Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis
Conditions: Ulcerative Colitis; Inflammatory Bowel Diseases Interventions: Drug: Infliximab; Drug: Adalimumab Sponsors: Vastra Gotaland Region Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
Conditions: Depressive Disorder, Major; Inflammation Interventions: Drug: Infliximab; Other: Placebo Sponsors: Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Conditions: Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis Interventions: Drug: Infliximab; Drug: Infliximab; Drug: Infliximab Sponsors: Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW; Celltrion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD
Conditions: Crohn ' s Disease Interventions: Drug: Infliximab-Dyyb Sponsors: Asan Medical Center; Seoul National University Hospital; Severance Hospital; Kyung Hee University Hospital; Kyungpook National University Hospital; Samsung Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials
inDuctIon tREatment With subCuTaneous Infliximab for Crohn's Disease
Conditions: Inflammatory Disease; Disease Crohn; Bowel Disease Interventions: Drug: Infliximab subcutaneous; Drug: Immunosuppressive Agents Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Celltrion Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials
TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
Conditions: Crohn Disease; Infliximab; Perianal Fistula Due to Crohn's Disease; Therapeutic Drug Monitoring; Magnetic Resonance Novel Index for Fistula Imaging in Crohn's Disease Score Interventions: Drug: TDM-based infliximab intravenous therapy; Drug: Standard infliximab intravenous therapy Sponsor: Asan Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
Conditions: Crohn Disease; Infliximab; Perianal Fistula Due to Crohn ' s Disease; Therapeutic Drug Monitoring; Magnetic Resonance Novel Index for Fistula Imaging in Crohn ' s Disease Score Interventions: Drug: TDM-based infliximab intravenous therapy; Drug: Standard infliximab intravenous therapy Sponsors: Asan Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Infliximab Biosimilar Remsima in Psoriasis
Condition: Psoriasis Intervention: Drug: Remsima Sponsor: Ghurki Trust and Teaching Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
